• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA 2021 Annual Report of Medical Device & IVD Registrations in China

NMPA 2021 Annual Report of Medical Device & IVD Registrations in China

Saturday, 26 February 2022 / Published in Medical Device, News, NMPA Registration in China

NMPA 2021 Annual Report of Medical Device & IVD Registrations in China

On January 27, 2022, the NMPA (National Medical Products Administration) issued the 2021 Annual Report for Medical Device and IVD Registrations.

In 2021, the NMPA received a total of 12,255 applications for the initial registration, registration renewals and changes in licensing items of Class III (Domestic and Overseas) and Class II (Overseas) medical devices, increased by 15.8% as compared to 2020. Amongst the 12,255 applications, the NMPA approved a total of 11,314 applications with an increase of 14.9% as compared to 2020. The NMPA handled a total of 1,854 filing applications of imported Class I medical devices, an increase of 0.5% as compared to 2020.

Table 1. NMPA – No. of Applications and Approvals for Medical Devices and IVDs

Chart 1. NMPA – No. of Applications and Approvals for Medical Devices and IVDs

Chart 2. Percentage Distribution of Three Types of NMPA Approvals

Chart 3. Percentage Distribution of Approvals for Medical Devices and IVDs

Chart 4. NMPA – No. of Registrations and Applications Approved from January 2016 to December 2021

Chart 5. NMPA – No. of New Registrations Approved from January 2021 to December 2021

In 2021, the NMPA approved 1,710 new registrations in total.

The provincial medical product administration (MPAs) authorities approved a total of 31,509 applications of China domestic Class II medical devices, an increase of 6.3% as compared to 2020.

The municipal medical product administration (MPAs) authorities handled a total of 26,773 filing applications of China domestic Class I medical devices, a decrease of 22.7% as compared to 2020.

The top five class II and III product groups of foreign origin to be registered in 2021 were:

1. Medical Imaging Equipment
2. Passive Implants Devices
3. Dental Instruments
4. Neurological and Cardiovascular Surgical Instruments
5. Ophthalmic Devices

The United States of America, Germany, Japan, Korea and Switzerland continue to have the highest number of initial registrations for overseas medical devices as last year, taking up to 72% of the total number of initial registrations for overseas medical devices.

List of Top 10 Countries – Exporting Medical Devices to China

  1. USA
  2. Germany
  3. Japan
  4. South Korea
  5. Switzerland
  6. Italy
  7. France
  8. United Kingdom
  9. Sweden
  10. Israel

Fast-track Approval for Medical Devices

NMPA received 249 applications for special review and approval of innovative medical devices and 41 applications for priority review. A total of 35 domestic medical devices have obtained the special approval to market as innovative medical devices in 2021.

From 2014 to 2021, the NMPA approved a total of 127 domestic innovative medical devices (104 local brands) and 7 foreign innovative medical devices (5 global brands).

Further information concerning this topic can be obtained from:
Cisema (Hong Kong) Limited
Tel.: +852 3462 2483
info@cisema.com
www.cisema.com/en

Tagged under: IVDs

What you can read next

May 2021 China Regulatory Round-up for Medical Devices
Vaccine Administration Law
Cosmetics enterprises quality and safety responsibilities
Cosmetics enterprises quality and safety responsibilities – Draft regulation issued

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Physicochemical characterization of nanomaterials

    Physicochemical characterization of nanomaterials used in medical devices – New guidelines issued

    Physicochemical characterization of nanomateria...
  • Registration of disposable light-proof infusion sets in China

    Registration of disposable light-proof infusion sets in China – Amended guidelines issued

    Registration of disposable light-proof infusion...
  • Registration of disposable blood separation devices in China

    Registration of disposable blood separation devices in China – Amended guidelines issued

    Registration of disposable blood separation dev...
  • Registration of disposable infusion devices in China

    Registration of disposable infusion devices in China – Amended guidelines issued

    Registration of disposable infusion devices in ...
  • Registration of blood dialyzers in China

    Registration of blood dialyzers in China – Amended guidelines issued

    Registration of blood dialyzers in China shall ...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP